Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision tag, Revision: v3.5.4, has been added to the page. This replaces the previous Revision: v3.5.3, indicating an updated version of the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the displayed study information.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2. This appears to be a minor metadata/UI update with no change to study information.SummaryDifference0.1%

- Check102 days agoChange DetectedRevision: v3.4.2 is now shown on the page, replacing Revision: v3.4.1. This appears to be a minor behind-the-scenes update with no user-facing content changes.SummaryDifference0.1%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.